McLaughlin Poll Finds Voters Oppose Government Intervention in the Private Market

April 9, 2025

EGWP marketplace medicaid Medicare

PCMA released results from a public opinion research conducted by McLaughlin & Associates showing that American voters in battleground states overwhelmingly oppose policies that interfere with the private market and believe drug companies should be held accountable for high drug prices. The survey found that 94% of battleground state voters are concerned with the high prices of prescription drugs with 57% blaming drug companies for the costs, 15% blaming the government, and only 10% blaming PBMs.

Further, 88% of respondents believe that Congress should hold pharmaceutical companies accountable for patent abuses and direct-to-consumer advertising instead of policies that interfere with the private market. Additionally, 82% are concerned that targeting rebate pass-through in the private market will take away a critical choice for employers.

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

survey results

Take the 1-Minute survey

Thank you for being a valued reader of Regulated Times. Take our brief, anonymous survey in less than one minute and help shape the future of Regulated Times.

As we continue to evolve the newsletter, we’d love to hear your thoughts. Your feedback will help us better understand what content is most valuable, whether the current publication frequency is meeting your needs, and how we can improve your overall experience.
read more >

June 19, 2026

EGWP marketplace medicaid Medicare

Initiatives

PCMA launches new affordability campaign

PCMA rolled out a new seven-figure multi-channel advertising campaign focused on affordability. The campaign, which has been covered by Bloomberg, Inside Health Policy, and Politico, will include digital, email, and streaming advertising, events, podcasts, a new microsite, and a suite of resources designed to better explain how PBMs work and the outsized value they deliver […]
read more >

June 10, 2026

EGWP marketplace medicaid Medicare